The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion

International Immunology

Volumn 9, Issue 6, 1997, Pages 805-813

  Rennert, Paul ^a,d   Furlong, Kimberly ^a   Jellis, Cindy ^a   Greenfield, Edward ^a   Freeman, Gordon J ^c   Ueda, Yuji ^b   Levine, Bruce ^b   June, Carl H ^b   Gray, Gary S ^a,e  

^a REPLIGEN CORPORATION   (United States)

^b NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BIOGEN   (United States)

^e PFIZER INC   (United States)

Author keywords

B7 1; CD28; CD80; CD86; CTLA 4; Cytokine; Fusion proteins; IgV; Soluble ligand

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; CELL SECRETION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CELL CYCLE; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES;

EID: 0030976246     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.6.805     Document Type: Article

References (37)

1. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349.
2. Bretscher, P. 1992. The two-signal model of lymphocyte activation twenty-one years later, Immunol. Today 13:74.
3. Linsley, P. S. and Ledbetter, J. A. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
4. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B. 1994. The B7 and CD28 receptor families, Immunol. Today 15:321.
5. Schwartz. R. H. 1992, Co-stimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.
6. Boise, L. H., Minn, A. J., Accacitti, M. A., June, C. H., Lindsten, T. and Thompson, C. B. 1995. CD28 stimulation can enhance cell survival by inducing the expression of Bcl-XI. Immunity 3:87.
7. Freeman, G. J., Freedman, A. S., Segil, J. M., Lee, G., Whitman, J. F. and Nadler, L. M. 1989. B7, a new member of the lg superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714.
8. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L. and Somoza, C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
9. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Jr, Lombard, L. A., Gray, G. S. and Nadler, L M. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell production. Science 262:909.
10. Gimmi, C. D., Freeman, G. J., Gribben, J. G., Sugita, K., Freedman, A. S., Morimoto, C. and Nadler, L. M. 1991. Cell surface antigen B7 provides a co-stimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl Acad. Sci. USA 88:6575.
11. Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K. and Ledbetter, J. A. 1991. Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and IL2 mRNA accumulation. J. Exp. Med. 173:721.
12. Hathcock, K. S., Laszlo, G., Pucillo, C., Linsley, P. and Hodes, R. H. 1994. Comparative analysis of B7-1 and B7-2 co-stimulatory ligands: expression and function. J. Exp. Med. 180:631.
13. Lanier, L. L., O'Fallon, S., Somoza, C., Phillips, J. H., Linsley, P. S., Okumura, K., Ito, D. and Azuma, M. 1995. CD80 (B7) and CD86 (B70) provide similar co-stimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
14. Freeman, G. J., Boussiotis, V. A., Anumunthan, A., Bernstein, G. M., Ke, X.-Y, Rennert, P. D., Gray, G. S., Gribben, J. G. and Nadler, L. M. 1995. B7-1 and B7-2 do not deliver identical co-stimulatory signals since B7-2 but not B7-1 co-stimulates the initial production of IL4. Immunity 2:523.
15. Matulonis, U., Dosiou, C., Freeman, G., Lamont, C., Mauch, P., Nadler, L. M. and Griffin, J. D. 1996. B7-1 is superior to B7-2 co-stimulation in the induction and maintenance of T-cell mediated anti-leukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J. Immunol. 156:1126.
16. Natesan, M., Razi-Wolf, Z. and Reiser, H. 1996. Co-stimulation of IL-4 production by murine B7-12 and B7-2 molecules. J. Immunol. 156:2783.
17. Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K. and Ledbetter, J. A. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
18. Boussiotis, V. A., Freeman, G. J., Gribben, J. G., Daley, J., Gray, G. S. and Nadler, L. M. 1993. Activated human B lymphocytes express three CTLA-4 counterreceptors that co-stimulate T-cell activation. Proc. Natl Acad. Sci. USA 90:11059.
19. Gribben, J. G., Freeman, G. J., Boussiotis, V. A., Rennert, P., Jellis, C. L., Greenfield, E., Barber, M., Restivo, Va. A., Jr, Ke, X., Gray, G. S. and Nadler, L. M. 1995. CTLA-4 mediates antigenspecific apoptosis of human T cells. Proc. Natl Acad. Sci. USA 92:811.
20. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
21. Damle, N. K., Klussman, K., Letze, G., Myrdal, S., Aruffo, A., Ledbetter, J. A. and Linsley, P. S. 1994. Co-stimulation of T lymphocytes with integrin ligands intracellular adhesion molecule1 or vascular adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J. Immunol. 152:2686.
22. Peach, R. J., Bajorath, J., Brady, W., Leytze, G., Greene, J., Naemura, J. and Linsley, P. S. 1994. Complementarity determining region 1 (CDR 1)- and CDR3-analogous regions in CTLA-4 and CD28 determine binding to B7-1. J. Exp. Med. 180:2049.
23. Morton, P. A., Fu, X.-T., Stewart, J. A. Giacoletto, K. S. White, S. L. Leysath, C. E., Evans, R. J., Shieh, J.-J. and Karr, R. W. 1996. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J. Immunol. 156:1047.
24. Selvakumar, A., Mohanraj, B. K., Eddy, R. L., Shows, T. B., White, P. C. and Dupont, B. 1992. Genomic organization and chromosomal localization of the human gene encoding the B-lymphocyte antigen B7. Immunogenetics 36:175.
25. Jellis, C. L., Wang, S. S., Rennert, P., Borriello, F., Sharpe, A. H., Green, N. G. and Gray, G. S. 1995. Genomic organization of the gene coding for the co-stimulatory human B lymphocyte antigen B7-2 (CD86). Immunogenetics 42:85.
26. Current Protocols in Molecular Biology. 1991. In Ausubel, F. M. Brent, R., Kingston, R. E., Moore, D. D., Smith, J. A., Seidman, J. G. and Struhl, K., eds, Current Protocols in Molecular Biology, Chapter 9.4. John Wiley, New York.
27. Kohler, G. and Milstein, C. 1975. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256:495.
28. + T cells and induce similar patterns of cytokine secretion in vitro. Int. Immunol. 7:891.
29. + T lymphocytes. J. Immunol. 148:1985.
30. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zemvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N. and Glimcher, L. H. 1995. B7-1 and B7-2 co-stimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:1.
31. Guo, Y., Wu, Y., Zhao, M., Kong, X.-P. and Liu, Y 1995. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA-4-binding site on immunoglobulin C-like domain. J. Exp. Med. 181:1345.
32. Inobe, M., Aoki, N., Linsley, P. S., Ledbetter, J. A., Abe, R., Murakami, M. and Ueda, T. 1996. The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation. J. Immunol. 157:582.
33. Borriello, F., Oliveros, J., Freeman, G. J., Nadler, L. M. and Sharpe, A. H. 1995. Differential expression of alternate mB7-2 transcripts. J. Immunol. 155:5490.
34. Davis, T. A., Craighead, N., Williams, A. J., Scadron, A., June, C. H. and Lee, K. P. 1996. Primary porcine endothelial cells express membrane-bound B7-2 (CD86) and a soluble factor that co-stimulate cyclosporin A-resistant and CD28 dependent human T cell proliferation. Int. Immunol. 7:1099.
35. Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A. and Peach, R. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
36. Fargeas, C. A., Truneh, A., Reddy, M., Hurle, M., Sweet, R. and Sekaly, R.-P. 1995. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA-4. J. Exp. Med. 182:667.
37. Peach, R.J., Bajorath, J., Naemura, J., Leytze, G., Greene, J., Aruffo, A. and Linsley, P. S. 1995. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J. Biol. Chem. 270:21181.